QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study 期刊论文 CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021 作者:  Wang, Wenxian;  Gu, Xiaodong;  Wang, Liping;  Pu, Xingxiang;  Feng, Huijing 收藏  |  浏览/下载：29/0  |  提交时间：2022/01/10 Non-small cell lung cancer  PD-L1  Immune checkpoint inhibitor  Immune-related adverse event   Molecular and Clinical Characteristics of Primary Pulmonary Lymphoepithelioma-Like Carcinoma 期刊论文 FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 卷号: 8 作者:  Fan, Ying;  Shan, Qianyun;  Gong, Jiali;  Qin, Jing;  Lu, Hongyang 收藏  |  浏览/下载：45/0  |  提交时间：2022/01/10 PPLELC  clinical characteristics  molecular characteristics  immunotherapy  PD-L1  TMB   Clinical Relevance of PD-L1 Expression and CD8+T Cells' Infiltration in Patients With Lung Invasive Mucinous Adenocarcinoma 期刊论文 FRONTIERS IN ONCOLOGY, 2021, 卷号: 11 作者:  Xu, Xiaoling;  Li, Na;  Wang, Ding;  Chen, Wei;  Fan, Yun 收藏  |  浏览/下载：39/0  |  提交时间：2021/08/31 invasive mucinous adenocarcinoma  lung cancer  PD-L1 expression  CD8+T cells  tumor microenvironment  genetic characteristics  treatment   Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition 期刊论文 CHINESE CHEMICAL LETTERS, 2021, 卷号: 32, 期号: 6, 页码: 1929-1936 作者:  Gao, Jing;  Zhang, Hanwu;  Zhou, Fengqi;  Hou, Bo;  Chen, Meiwan 收藏  |  浏览/下载：17/0  |  提交时间：2021/08/17 Cancer immunotherapy  siRNA delivery  Acid-activatible micelleplex  CDK4  6 inhibitor  PD-L1 knockdown   Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy 期刊论文 BRITISH JOURNAL OF PHARMACOLOGY, 2021, 页码: 20 作者:  Liu, Chenglong;  Zhou, Feilong;  Yan, Ziqin;  Shen, Lian;  Zhang, Xichen 收藏  |  浏览/下载：26/0  |  提交时间：2021/06/11 immunotherapy  PD-1/PD-L1  TGF-beta  tumour immune microenvironment   Molecular Characteristics of Genes and the Immune Microenvironment of a Rare Chest Malignant Tumor (Pulmonary Clear Cell Sarcoma): A Case Report 期刊论文 FRONTIERS IN ONCOLOGY, 2021, 卷号: 11 作者:  Xu, Xiaoling;  Wang, Ding;  Wu, Wei;  Lu, Hongyang 收藏  |  浏览/下载：23/0  |  提交时间：2021/05/06 clear cell sarcoma  next-generation sequencing  lung  EWS-ATF1  PD-L1  TIGIT   Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy 期刊论文 NEOPLASIA, 2021, 卷号: 23, 期号: 3, 页码: 281-293 作者:  Wang, Fengling;  Ye, Wenling;  Wang, Shuang;  He, Yongxing;  Zhong, Haiyang 收藏  |  浏览/下载：33/0  |  提交时间：2021/12/10 PD-1  PD-L1  Inhibitor  APBC  Cancer immunotherapy   The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma 期刊论文 JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 卷号: 12 作者:  Shen, Dijian;  Chen, Qixun;  Wu, Jie;  Li, Jianqiang;  Tao, Kaiyi 收藏  |  浏览/下载：39/0  |  提交时间：2021/04/26 Neoadjuvant immunotherapy  esophageal squamous cell carcinoma (ESCC)  thoracic surgery  programmed death 1 (PD-1)   Original Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma 期刊论文 TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14 作者:  Jin, Ting;  Zhang, Qun;  Jin, Qi-Feng;  Hua, Yong-Hong;  Chen, Xiao-Zhong 收藏  |  浏览/下载：18/0  |  提交时间：2022/01/25 Nasopharyngeal carcinoma  Metastasis  Chemotherapy  Recurrence  Anti-PD1 checkpoint inhibitor   Remarkable Response of Toripalimab Combined with Chemotherapy in Sarcomatoid Carcinoma of Palatine Tonsil: A Case Report 期刊论文 JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2021, 卷号: 14 作者:  Huang, Jiahuan;  Lei, Lei;  Chen, Bo;  Pan, Guoqiang;  Wang, Xiaojiao 收藏  |  浏览/下载：34/0  |  提交时间：2021/04/26 chemotherapy  combination therapy  palatine tonsil cancer  PD-1 inhibitor  sarcomatoid carcinoma